ACNE
None
WATER RETENTION
None
HBR
None
HEPATOTOXICITY
None
AROMATIZATION
None
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
SUBSTANCE
GHRH Peptide
Discover the power of Tesamorelin, a transformative growth hormone-releasing factor (GRF) designed to target and reduce excess abdominal fat associated with lipodystrophy, particularly in HIV-positive patients. This innovative peptide therapy is specifically formulated to combat the effects of certain HIV treatments, helping to restore a more balanced physique.
Important Note: While Tesamorelin is effective for those with lipodystrophy, it is not intended for general weight loss or obesity treatment. It is exclusively approved for mitigating abdominal fat in individuals diagnosed with this condition.
Use Limitations:
Current research on the long-term cardiovascular safety of Tesamorelin is limited, making it essential to monitor patient response closely. If there is no significant reduction in visceral fat?as measured by waist circumference or CT scans?consider reevaluating the treatment plan. Tesamorelin does not promote weight management nor does it enhance adherence to antiretroviral therapies in HIV patients.
General Dosing Guidelines:
The recommended dosage of Tesamorelin is 2 mg, administered subcutaneously once daily. For optimal results, inject into the abdomen, ensuring to rotate injection sites to minimize discomfort and avoid areas with scar tissue, bruises, or the navel.
Reconstitution Instructions:
To prepare Tesamorelin for injection, reconstitute it with the provided diluent. Simply mix a 2 mg vial of Tesamorelin with 2.1 mL of the diluent by gently rolling the vial in your hands for 30 seconds?avoid vigorous shaking. Further reconstitution details can be found in the INSTRUCTIONS FOR USE leaflet included with your Tesamorelin and diluent packaging. After reconstitution, administer Tesamorelin immediately and dispose of any unused solution. Do not freeze or refrigerate any remaining mixture.
Administration:
Before injecting, visually inspect the reconstituted Tesamorelin solution for clarity and color. Only inject if the solution is clear, colorless, and free of any particles. Administer the injection subcutaneously into the abdominal area, rotating sites as needed, and steering clear of scar tissue, bruises, or the navel.